XWELL Inc.
Diagnostics & Research
Healthcare
XWEL
5.26 M shares
NASDAQ US
traded
21 Jul 2025
listed
no
open
1.10
52 week high
2.52
high
1.39
52 week low
0.00
low
1.04
growth
-36.54 %
previous Close
1.37
P/E ratio
-1
market cap
5.05 M
div yield
0
usd
Mar 2025
qoq
revenue
7.02 M
-16.61 %
net incoming
-4.72 M
0.65 %
eps
-1.44 %
-46.45 %
eps surprise
0.00 %
net profit margin
-67.19 %
-10.00 %
operating incoming
-3.16 M
33.78 %
net change in cash
-900.00 K
14.61 %
cash on hand
3.65 M
-16.38 %
cost of revenue
5.70 M
-10.44 %
top top